Welcome to Finextra. We use cookies to help us to deliver our services. You may change your preferences at our Cookie Centre.

Alviss.ai CEO and Founder Dr. Pavel Overtchouk talks about how the company’s stroke prediction software seeks to be the first attempt to apply predictive medicine to cardiovascular interventions and ...

EAGAN, Minn., March 21, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (POAI), a science-driven company leveraging its proprietary artificial intelligence and machine learning capabilities, ...

Comparison of predicted benefit using RS clin versus observed benefit in a U.S. registry of stage I ER-positive HER2-negative high oncotype DX RS breast cancer. This is an ASCO Meeting Abstract from ...